Related references
Note: Only part of the references are listed.Extracellular vesicular Wnt7b mediates HPV E6-induced cervical cancer angiogenesis by activating the β-catenin signaling pathway
Jun-Jun Qiu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
miR-640 aggravates intervertebral disc degeneration via NF-κB and WNT signalling pathway
Wengang Dong et al.
CELL PROLIFERATION (2019)
miR-342-5p inhibits osteosarcoma cell growth, migration, invasion, and sensitivity to Doxorubicin through targeting Wnt7b
Qing Liu et al.
CELL CYCLE (2019)
Combination with TMZ and miR-505 inhibits the development of glioblastoma by regulating the WNT7B/Wnt/β-catenin signaling pathway
Cong Zhang et al.
GENE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Wnt signaling in human and mouse breast cancer: Focusing on Wnt ligands, receptors and antagonists
Ping Yin et al.
CANCER SCIENCE (2018)
MicroRNA-424 serves an anti-oncogenic role by targeting cyclin-dependent kinase 1 in breast cancer cells
Dan Xie et al.
ONCOLOGY REPORTS (2018)
Wnt proteins synergize to activate β-catenin signaling
Anshula Alok et al.
JOURNAL OF CELL SCIENCE (2017)
Wnt ligand presentation and reception: from the stem cell niche to tissue engineering
Kate M. Mills et al.
OPEN BIOLOGY (2017)
Hydrogen sulfide promotes angiogenesis by downregulating miR-640 via the VEGFR2/mTOR pathway
Yu Zhou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2016)
MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway
Wentao Si et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2016)
Wnt3a suppresses Wnt/β-catenin signaling and cancer cell proliferation following serum deprivation
Qingqing He et al.
EXPERIMENTAL CELL RESEARCH (2016)
miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2
Kaiyao Hua et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: New trends in the development of miRNA therapeutic strategies in oncology
Roberto Gambari et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer
Gloria Bertoli et al.
THERANOSTICS (2015)
WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer
M. L. King et al.
ONCOGENE (2015)
WNT7B mediates autocrine Wnt/β-catenin signaling and anchorage-independent growth in pancreatic adenocarcinoma
M. D. Arensman et al.
ONCOGENE (2014)
WNT7B Promotes Bone Formation in part through mTORC1
Jianquan Chen et al.
PLOS GENETICS (2014)
The WNT signaling pathway from ligand secretion to gene transcription: Molecular mechanisms and pharmacological targets
Hoeke A. Baarsma et al.
PHARMACOLOGY & THERAPEUTICS (2013)
The wnt/beta-catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer
Taj D. King et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Wnt9a signaling is required for joint integrity and regulation of Ihh during chondrogenesis
Daniela Spaeter et al.
DEVELOPMENT (2006)
Share Paper
